T2 BIOSYSTEMS
T2 Biosystems is a private company developing a next-generation medical diagnostic platform that enables rapid and accurate diagnostic tests of all types on a single, easy-to-use instrument. The company's proprietary technology combines nanotechnology and miniaturized magnetic resonance (MR) technology and eliminates the need for costly and time-consuming sample preparation.
T2 BIOSYSTEMS
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2006-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.t2biosystems.com
Total Employee:
101+
Status:
Active
Contact:
+1 781 457 3920
Email Addresses:
[email protected]
Total Funding:
316.63 M USD
Technology used in webpage:
Domain Not Resolving Google Maps IPv6 U.S. Server Location Amazon Virginia Region Microsoft IIS 10 Amazon Route 53 Gravity Forms Ruby On Rails Token
Similar Organizations
HeartFlow
HeartFlow is a medical technology company that provides new methods of diagnosis and treatment of cardiovascular disease.
Lumicell
Lumicell is a biotechnology company that develops and markets image-guided cancer surgery solutions.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Prolocor
Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.
Symvivo Corporation
Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases.
Thrive Earlier Detection
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
CRG
CRG investment in Post-IPO Equity - T2 Biosystems
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - T2 Biosystems
Biomedical Advanced Research and Development Authority (BARDA)
Biomedical Advanced Research and Development Authority (BARDA) investment in Grant - T2 Biosystems
CARB-X
CARB-X investment in Grant - T2 Biosystems
CRG
CRG investment in Post-IPO Debt - T2 Biosystems
Canon
Canon investment in Post-IPO Equity - T2 Biosystems
Goldman Sachs
Goldman Sachs investment in Series E - T2 Biosystems
Flagship Pioneering
Flagship Pioneering investment in Series E - T2 Biosystems
Aisling Capital
Aisling Capital investment in Series E - T2 Biosystems
WS Investments
WS Investments investment in Series E - T2 Biosystems
Key Employee Changes
Date | New article |
---|---|
2021-11-04 | T2 Biosystems Hires Industry Veteran Brett Giffin as Chief Commercial Officer |
Official Site Inspections
http://www.t2biosystems.com Semrush global rank: 6.79 M Semrush visits lastest month: 1.02 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "T2 Biosystems"
T2 Biosystems - Crunchbase Company Profile & Funding
T2 Biosystems is a private company developing a next-generation medical diagnostic platform that enables rapid and accurate diagnostic tests of all types on a single, easy-to-use instrument.See details»
Overview | T2 Biosystems Inc.
Dec 18, 2024 Summary Toggle T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results: Achieved record fourth quarter and full-year 2024 sepsis product โฆSee details»
T2 Biosystems initiates major layoffs, seeks asset sale
Feb 20, 2025 T2 Biosystems (OTC: TTOO), Inc., a medical device company based in Lexington, Massachusetts, has announced a significant โฆSee details»
T2 Biosystems (TTOO) Company Profile & Description - Stock โฆ
1 day ago Company profile for T2 Biosystems, Inc. (TTOO) with a description, list of executives, contact details and other key facts.See details»
T2 Biosystems
Jul 16, 2025 T2 Biosystems was founded in 2006 by co-founders Dr. Jack Phillips, Prof. Cynthia Mullen, and Dr. Ross Johnson. Its rapid diagnostic platform uses a non-culture-based โฆSee details»
T2 Biosystems - Craft
Oct 29, 2024 T2 Biosystems has 5 employees across 16 locations and $7.19 m in annual revenue in FY 2023. See insights on T2 Biosystems including office locations, competitors, โฆSee details»
T2 Biosystems - 2025 Company Profile & Team - Tracxn
6 days ago T2 Biosystems has raised a total funding of $454M over 10 rounds. Its first funding round was on Jan 01, 2006. Its latest funding round was a Grant (prize money) round on Mar โฆSee details»
T2 Biosystems, Inc.
T2 Biosystems, Inc. Thank you for visiting the website for T2 Biosystems, Inc. (โCompanyโ), an in vitro diagnostics company formerly based in โฆSee details»
T2 Biosystems (USA) Funding: $316.6M - Medical โฆ
Jul 7, 2025 T2 Biosystems is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products โฆSee details»
T2 Biosystems - Products, Competitors, Financials, Employees ...
Aug 7, 2014 Financial Comparison: ClearPoint Neuro (NASDAQ:CLPT) vs. T2 Biosystems (NASDAQ:TTOO) Jun 14, 2025. Financial Comparison: ClearPoint Neuro (NASDAQ:CLPT) โฆSee details»
Company T2 Biosystems, Inc. - MarketScreener.com
Jun 13, 2020 T2 Biosystems, Inc. is an in vitro diagnostics company focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. Its technology enables detection of โฆSee details»
Shareholder Information - T2 Biosystems Inc.
American Stock Transfer & Trust Company Toll-free: (800) 937-5449 or International: (718) 921-8124 Operations Center 6201 15th Avenue Brooklyn, NY 11219See details»
T2 Biosystems, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for T2 Biosystems, Inc. of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»
About T2 International - T2 Biosystems OUS
The T2Dx Instrument, the T2Bacteria and T2Candida Panels have received marketing authorization from the U.S. Food and Drug Administration. All other T2 Biosystems products โฆSee details»
T2 Biosystems, Inc. | Science Company | Labroots
Feb 14, 2024 T2 Biosystems is focused on developing innovative diagnostic products to improve patient health. With two FDA-cleared products targeting sepsis and a range of additional โฆSee details»
T2 Biosystems Announces Exploration of Strategic Alternatives and โฆ
LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic โฆSee details»
T2 Biosystems - Flagship Pioneering
Founded. 2006. Status. Historical; Domain. Human Health; Latest News from T2 Biosystems. T2 Biosystems Receives CE Mark for T2Bacteriaโข Panel Enabling Commercialization In Europe โฆSee details»
T2 Biosystems Announces Plans to License its Proprietary โฆ
Dec 9, 2024 T2 Biosystemsโ expanded business model is intended to generate non-dilutive capital through licensing agreements that provide access to the Companyโs patented direct โฆSee details»
T2 Biosystems Receives FDA 510(k) Clearance for the T2Biothreat โฆ
The only FDA-cleared multi-target biothreat product developed and manufactured by a U.S. owned company. LEXINGTON, Mass., Sept. 19, 2023 (GLOBE NEWSWIRE) -- T2 โฆSee details»
Share ownership T2 Biosystems, Inc. - MarketScreener.com
Jul 18, 2025 T2 Biosystems, Inc. is an in vitro diagnostics company focused on the detection of sepsis-causing pathogens and antibiotic resistance genes. Its technology enables detection of โฆSee details»